SCHEMBL6279964

SCHEMBL6279964

CCOC(=O)c1cn(C)c2oc(CCl)cc2c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BAZ2B Q9UIF8 1/20 0.50
BAZ2A Q9UIF9 1/20 0.50
LMNA P02545 2/20 0.43
POLB P06746 1/20 0.41
ALDH1A1 P00352 3/20 0.41
KMT2A Q03164 2/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 2/20 0.41
TDP1 Q9NUW8 1/20 0.40
MAOB P27338 1/20 0.40
NPC1 O15118 2/20 0.39
HPGD P15428 1/20 0.39
HSD17B10 Q99714 1/20 0.39
RAB9A P51151 1/20 0.38
RXFP1 Q9HBX9 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
PIM1 P11309 1/20 0.38
IRAK1 P51617 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6278064 0.81 BAZ2B (0.46) BAZ2BBAZ2ALMNAPOLBALDH1A1
SCHEMBL6282326 0.81 ALDH1A1 (0.56) BAZ2BBAZ2ALMNAPOLBALDH1A1
SCHEMBL6278034 0.81 STAT3 (0.45) BAZ2BBAZ2ALMNAPOLBALDH1A1
SCHEMBL6839742 0.77 BAZ2B (0.49) BAZ2BBAZ2ALMNAPOLBALDH1A1
SCHEMBL6281429 0.75 MAOB (0.48) BAZ2BBAZ2ALMNAALDH1A1KMT2A
SCHEMBL6277482 0.73 MAOB (0.36) BAZ2BBAZ2ALMNAKMT2AMAPT
SCHEMBL18322320 0.72 FUCA1 (0.49) LMNAALDH1A1MAPTKDM4EMAOB
SCHEMBL10341233 0.72 GABRA1 (0.53) BAZ2BBAZ2ALMNAKMT2AMAPT
SCHEMBL6277614 0.71 KCNH2 (0.54) KMT2AMAPT
SCHEMBL10084828 0.71 LMNA (0.58) BAZ2BBAZ2ALMNAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6878705-B2 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamide antiviral agents PFIZER (US) 2005-04-12 US disclosed
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY 2004-12-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259907-A1 4-OXO-4,7-DIHYDROFURO[2,3-B]PYRIDINE-5-CARBOXAMIDE ANTIVIRAL AGENTS IL4, ZC3HAV1, IRF3 BAZ2B 677/4885BAZ2A 1007/4885LMNA 4193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.